Presentation TCT 2016 ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation Presenter: Howard C. Herrmann, Robert J. de Winter, Hiroki Shiomi November 01, 2016
Presentation TCT 2016 2016 CTO Revascularization Update Presenter: Sripal Bangalore, George D. Dangas, Khaldoon Alaswad November 01, 2016
Presentation TCT 2016 PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities Presenter: Howard C. Herrmann, Robert J. de Winter, Wayne B. Batchelor November 01, 2016
Presentation TCT 2016 Diagnosis and Treatment of Erosion in ACS: The EROSION Study Presenter: John A. Ambrose, Peter H. Stone, Ik-Kyung Jang November 01, 2016
Presentation TCT 2016 Case Conclusion: How Did We Revascularize This Patient? Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos November 01, 2016
Presentation TCT 2016 Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016! Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Hitinder S. Gurm November 01, 2016
Presentation TCT 2016 Designing a Complication-Free DCB: Is It Possible or Necessary? Presenter: Koen Deloose, William A. Gray, Juan F. Granada November 01, 2016
Presentation TCT 2016 Detecting and Differentiating Plaque Erosion vs Rupture and Does It Matter? Presenter: John A. Ambrose, Peter H. Stone, Giulio Guagliumi November 01, 2016
Presentation TCT 2016 2016 STEMI PCI Update: Evidence and Guidelines Presenter: Sripal Bangalore, George D. Dangas, Sanjit S. Jolly November 01, 2016
Presentation TCT 2016 Case Introduction: How Would You Revascularize This Patient? Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos November 01, 2016
Presentation TCT 2016 COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary Artery Disease Presenter: Howard C. Herrmann, Robert J. de Winter, Giora Weisz November 01, 2016
Presentation TCT 2016 Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal Presenter: John A. Ambrose, Peter H. Stone, Guillermo Tearney November 01, 2016
Presentation TCT 2016 Announcing the NIH-sponsored HYBRID Revascularization Trial Presenter: John D. Puskas, Gregg W. Stone November 01, 2016
Presentation TCT 2016 2016 DAPT Update: Evidence and Guidelines Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla November 01, 2016
Presentation TCT 2016 NIRS Detection of Vulnerable Plaque: The Story Is Intensifying Presenter: John A. Ambrose, Peter H. Stone, David Erlinge November 01, 2016
Presentation TCT 2016 Lesion Optimization Before PCI: Role of Imaging/Atherectomy Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux November 01, 2016
Presentation TCT 2016 Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study) Presenter: John D. Puskas, Gregg W. Stone November 01, 2016
Presentation TCT 2016 What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? Presenter: John A. Ambrose, Peter H. Stone November 01, 2016
Presentation TCT 2016 Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations Presenter: John D. Puskas, Gregg W. Stone, John S. Douglas Jr November 01, 2016
Presentation TCT 2016 The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer Presenter: John A. Ambrose, Peter H. Stone, James E. Muller November 01, 2016